Event bio
21 - 22 May, 2025
Berlin
As the pharmaceutical regulatory landscape evolves, advancements in technology and AI are reshaping how regulations are developed and enforced. How will your company adapt to the challenges and opportunities posed by data-driven submissions and digital health technologies?
The 5th Annual Pharmaceutical Regulatory Affairs Summit will cover key topics such as global partnerships in regulatory affairs, enhancing submissions through AI, and the evolving EU pharmaceutical regulations. Join us to gain valuable insights from industry leaders and network with senior decision-makers, while exploring the future of pharmaceutical regulation.
As the pharmaceutical regulatory landscape evolves, advancements in technology and AI are reshaping how regulations are developed and enforced. How will your company adapt to the challenges and opportunities posed by data-driven submissions and digital health technologies?
The 5th Annual Pharmaceutical Regulatory Affairs Summit will cover key topics such as global partnerships in regulatory affairs, enhancing submissions through AI, and the evolving EU pharmaceutical regulations. Join us to gain valuable insights from industry leaders and network with senior decision-makers, while exploring the future of pharmaceutical regulation.
Who Should Attend
Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from the pharmaceutical industry involved in:
- Regulatory Affairs
- Regulatory Intelligence
- Regulatory Policy
- Regulatory Compliance
- Regulatory Operations
- Regulatory Project Management
- Regulatory Information Management
- Regulatory Devices
- Regulatory Strategy
- Regulatory Submission
- Regulatory Sciences
- Regulatory Documentation
- Regulatory Labelling
- Regulatory Development
- Data Collection
- Data Management
- Lifecycle Management
- Regulatory Writing
- Scientific Affairs
Look at the Main Topics
Of Our Conference
- 01EU pharma legislation reform: What it means for regulatory affairs
- 02Challenges in collaborative efforts between big pharma and regulatory agencies
- 03Exploring the journey of eCTD 4.0
- 04Digital transformation and AI synergy
- 05Leveraging RWE to strengthen collaborations with regulatory authorities
- 06Achieving the right balance between personalised care and regulatory compliance
